Becton Dickinson & Company
Open
$144.89
Prev. Close
$144.82
High
$145.33
Low
$144.78
Market Snapshot
$41.33B
36.3
5.96
$20.64B
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Recently from Cashu
Becton Dickinson Launches Innovative Elyra™ Thulium Fiber Laser System for Urologic Care
Becton, Dickinson and Company (Ticker: BDX) capitalizes on innovation in urologic care with the launch of its new Elyra™ Thulium Fiber Laser (TFL) System. This cutting-edge technology is specifically…
Becton Dickinson Appoints New CFO Amid Mixed Financial Results and Losses
Becton Dickinson & Company (Ticker: BDX) announces a significant shift in its executive leadership, appointing Vitor Roque as the new executive vice president and chief financial officer. This transit…
Becton Dickinson Partners with Wellstar Health to Enhance Medication Management with AI Technology
Becton Dickinson & Company (Ticker: BDX) has announced a significant partnership with Wellstar Health System aimed at enhancing medication management through the deployment of AI-powered technologies.…
Becton Dickinson Launches CentroVena One™: A Breakthrough in Central Venous Catheter Insertion
Becton Dickinson & Company (BD) has launched its innovative BD® CentroVena One™ Insertion System, marking a significant advancement in the medical technology sector aimed at enhancing patient safety a…